Aims Clopidogrel is the most commonly prescribed thienopyridine as part of dual anti-platelet therapy for the treatment of ...

Monthly measurements of platelet aggregation revealed that AZD6140 was a significantly more potent inhibitor of aggregation (at both doses) than was clopidogrel and that the effects of AZD6140 ...

Unfortunately the authors do not make any mention of platelet aggregation inhibitors. In context of an expert report, the case of a patient was worked up in which, after a biopsy of a hepatic ...

revealing that SSRIs can inhibit platelet aggregation. This inhibition is particularly pronounced with serotonin-affecting antidepressants, which may lead to an increased risk of bleeding events ...

When given as an intravenous bolus, immediate and full platelet inhibition of ADP-induced platelet aggregation was observed. The clinical efficacy and safety of elinogrel will be further evaluated ...

IPA: Inhibition of platelet aggregation; iv.: Intravenous. The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or ...

Aspirin inhibits platelet aggregation by irreversible inhibition of platelet cyclooxygenase and thus inhibits the generation of thromboxane A2, a powerful inducer of platelet aggregation and ...

The first patient has been enrolled in a Phase 1 trial by the NHLBI that's evaluating fostamatinib as a treatment for sickle cell disease.